Skip to main content
. 2012 Mar 13;7(1):98–105. doi: 10.1007/s12072-012-9354-7

Fig. 2.

Fig. 2

Percentage of patients with detectable viremia and viral proteins after HBsAg seroclearance documented by a conventional assay (n = 329). HBsAg hepatitis B surface antigen, anti-HBs antibody to the hepatitis B surface antigen, HBcrAg hepatitis B core-related antigen